Combined cisplatin and gemcitabine for non-small cell lung cancer: Influence of scheduling on toxicity and drug delivery

Seminars in Oncology

Volumn 25, Issue 4 SUPPL., 1998, Pages 35-43

  Abratt, R P ^a   Sandler, A ^a   Crino, L ^a   Steward, W P ^a   Shepherd, F A ^a   Green, M R ^a   Nguyen, B ^a   Peters, G J ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYTOTOXIC AGENT; GEMCITABINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; DRUG TOLERABILITY; HUMAN; LIVER TOXICITY; LUNG NON SMALL CELL CANCER; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; SEPSIS; THROMBOCYTOPENIA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; CLINICAL TRIALS, PHASE II; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED;

EID: 0031904963     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)